Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bonyf NV's revenue for the
six
months ended in Dec. 2024 was €0.28 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.28 Mil.
Bonyf NV's Revenue per Share for the
six
months ended in Dec. 2024 was €0.48.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.48.
Warning Sign:
Bonyf NV revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Bonyf NV was -9.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -50.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 5 years, Bonyf NV's highest 3-Year average Revenue per Share Growth Rate was -50.90% per year. The lowest was -54.10% per year. And the median was -52.50% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Bonyf NV Revenue Related Terms
Bonyf NV Revenue Historical Data
* Premium members only.
The historical data trend for Bonyf NV's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV Revenue Chart
Bonyf NV Annual Data
Trend
Dec19
Dec20
Dec22
Dec23
Dec24
Revenue
3.20
2.37
0.28
0.31
0.28
Bonyf NV Semi-Annual Data
Dec19
Dec20
Dec22
Dec23
Dec24
Revenue
3.20
2.37
0.28
0.31
0.28
XPAR:MLBON vs ISRG, BDX, MDLN: Revenue Comparison
For the Medical Instruments & Supplies subindustry, Bonyf NV's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonyf NV Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonyf NV's Revenue distribution charts can be found below:
* The bar in red indicates where Bonyf NV's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.28 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV (XPAR:MLBON) has a Revenue of €0.28 Mil as of Dec. 2024. Revenue is the total amount a company generates as sales through its operations. View historical data on Bonyf NV and its competitors.
Is Bonyf NV's Revenue too high?
Bonyf NV's current Revenue is €0.28 Mil. Overall, Bonyf NV has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonyf NV's Revenue compare to ISRG and BDX?
Bonyf NV's Revenue of €0.28 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Bonyf NV and its competitors. Bonyf NV's current Revenue is €0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonyf NV stock overvalued right now?
Based on GuruFocus' analysis, Bonyf NV (XPAR:MLBON) is currently considered Possible Value Trap. The stock's GF Value™ is €8.53, compared to a current price of €2.48 — trading 70.9% below its estimated fair value. The current Revenue is €0.28 Mil. Bonyf NV's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Bonyf NV (XPAR:MLBON), the current Revenue is €0.28 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonyf NV (XPAR:MLBON) Overvalued in 2026?
Based on GuruFocus' analysis, Bonyf NV stock appears to be undervalued.
The current stock price of €2.48 is trading 70.9% below its estimated GF Value™ of €8.53.
GuruFocus considers Bonyf NV to be Possible Value Trap.
Key valuation signals for XPAR:MLBON:
Revenue: €0.28 Mil
GF Value™: €8.53 vs. price of €2.48 (70.9% below fair value)
No single metric tells the full story. See the XPAR:MLBON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonyf NV specializes in developing, producing and selling cutting-edge oral & dental care products. It is a forward-thinking company committed to revolutionizing oral care through innovation and research.
35GF Score
Get the complete analysis for XPAR:MLBON
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBON has been successfully added to your 
